Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of bumetanide in inhibiting tumor cell proliferation

A tumor cell proliferation, tumor cell technology, applied in the application field of bumetanide in inhibiting tumor cell proliferation, can solve the problem of renal tubule ineffectiveness, etc.

Active Publication Date: 2018-04-17
BEIJING PROTEOME RES CENT +1
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Bumetanide is a diuretic that mainly inhibits the active reabsorption of NaCl in the thick-walled segment of the ascending branch of the loop of Henle of the renal tubule, and reabsorbs NaCl in the proximal tubule. + Also inhibits, but has no effect on distal tubules

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of bumetanide in inhibiting tumor cell proliferation
  • Application of bumetanide in inhibiting tumor cell proliferation
  • Application of bumetanide in inhibiting tumor cell proliferation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Example 1, the inhibitory effect of bumetanide on A549 cells

[0024] The CCK-8 kit was used to detect the inhibitory effect of bumetanide on A549 cells, and the specific steps were as follows:

[0025] 1. Take a 96-well plate: prepare A549 cells in the logarithmic growth phase into a cell suspension (in the cell suspension, the concentration of A549 cells is 30 cells / microliter) and inoculate them into the test wells and control wells of the 96-well plate , 100 microliters per well; add the complete medium to the blank well of the 96-well plate, 100 microliters per well; then place the 96-well plate at 37°C, 5% CO 2 Cultivate in the incubator for 24h.

[0026] 2. After completing step 1, take the 96-well plate and suck out the culture solution in the well: add different volumes of bumetanide mother solution and complete medium to each well of the test well (so that the volume of the culture system in each well of the test well is equal, Both are 100 microliters, and ...

Embodiment 2

[0029] Example 2, the inhibitory effect of bumetanide on HCT116 cells

[0030]The CCK-8 kit was used to detect the inhibitory effect of bumetanide on HCT116 cells, and the specific steps were as follows:

[0031] 1. Take a 96-well plate: prepare HCT116 cells in the logarithmic growth phase into a cell suspension (in the cell suspension, the concentration of HCT116 cells is 40 cells / microliter) and inoculate them into the test wells and control wells of the 96-well plate , 100 microliters per well; add the complete medium to the blank well of the 96-well plate, 100 microliters per well; then place the 96-well plate at 37°C, 5% CO 2 Cultivate in the incubator for 24h.

[0032] 2. After completing step 1, take the 96-well plate and suck out the culture solution in the well: add different volumes of bumetanide mother solution and complete medium to each well of the test well (so that the volume of the culture system in each well of the test well is equal, Both were 100 microlite...

Embodiment 3

[0035] Example 3, the inhibitory effect of bumetanide on K562 cells

[0036] The CCK-8 kit was used to detect the inhibitory effect of bumetanide on K562 cells, and the specific steps were as follows:

[0037] 1. Take a 96-well plate: prepare K562 cells in the logarithmic growth phase into a cell suspension (in the cell suspension, the concentration of K562 cells is 120 cells / microliter) and inoculate them into the test wells and control wells of the 96-well plate , 50 microliters per well; add complete medium to blank wells of a 96-well plate, 50 microliters per well.

[0038] 2. After completing step 1, take a 96-well plate: add different volumes of bumetanide mother solution and complete medium to each well of the test well (so that the volume of the culture system in each well of the test well is equal, 50 microliters, cloth The final concentrations of Metanide in the culture system were 1, 2, 4, 8, 16, 32, 64, and 128 μg / ml respectively, and each concentration was set up...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses the application of bumetanide in inhibiting tumor cell proliferation. The invention provides the application of bumetanide in the preparation of drugs for inhibiting tumor cells. The tumor cells may be lung adenocarcinoma cells, colon cancer cells, leukemia cells, esophageal cancer cells, cervical cancer cells or breast cancer cells. The tumor cells may specifically be A549 cells, HCT116 cells, K562 cells, Eca109 cells, Hela cells, Jurkat cells or MCF7 cells. The invention has great value for the treatment of tumors.

Description

technical field [0001] The invention relates to the application of bumetanide in inhibiting tumor cell proliferation. Background technique [0002] Cancer, also known as malignant tumor (Malignant neoplasm), is a disease caused by the abnormal mechanism of controlling cell growth and proliferation. In addition to growing out of control, cancer cells can also locally invade the surrounding normal tissues and even transfer to other parts of the body through the internal circulatory system or lymphatic system. Common cancers include lung cancer, colon cancer, leukemia, esophageal cancer, cervical cancer, and breast cancer. Lung cancer: Cough is an early symptom of lung cancer. It is characterized by paroxysmal irritating cough. If there is no improvement after 2 weeks of anti-inflammatory treatment, you should be alert to the possibility of lung cancer, or coughing on the basis of the original chronic cough Another warning sign of lung cancer is intermittent repeated small am...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/196A61P35/00A61P35/02
Inventor 姜颖贺福初徐辰孙薇魏汉东
Owner BEIJING PROTEOME RES CENT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com